entertainment -WSS

entertainment

author：hotspot 2025-09-30 16:28:56 - browse：78

Yichuan Cao/Sipa USA via AP Images

Gilead Sciences said Monday that Trodelvy, its “smart-bomb” medicine that combines an antibody with chemotherapy, did not significantly extend the lives of patients with metastatic non-small cell lung cancer when given after a first treatment failed.

The result, from a closely watched study called Evoke-01, will be seen as a disappointment by investors and oncologists alike.

Drugs like Trodelvy, known as antibody drug conjugates, are one of the hottest areas in oncology. The idea is that these medicines combine an antibody, which is triggered when it binds to a protein on a cancer cell, with a “payload” of chemotherapy that poisons the cancer.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen
Next article： Bring on the sabbaticals for nurses

hotspot

WSS

Louisiana bill approved classifying abortion pills as controlled substances

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

Cancer, immunology, HIV research ensnared in fetal tissue politics

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

Yancopoulos of Regeneron works to expand Dupixent success

Medicare Advantage insurers pressure Biden for bigger payments

hotspot

entertainment

Wikipedia

Medical leaders decry Supreme Court decision on affirmative action

Ozempic cut risk of death in diabetes patients with chronic kidney disease

Bright Health sells Medicare Advantage business to Molina

Louisiana bill approved classifying abortion pills as controlled substances

FDA approval of Sarepta Duchenne genetic therapy gives me hope

U.S. death rates show how politics are affecting public health

The high cost of giving birth even with insurance

Medicare Advantage insurers pressure Biden for bigger payments

Trump demands the U.S. pay no more for drugs than other countries … again

Guardant Health colon cancer test endorsed by FDA advisory panel

focus

Testing GLP

Why some fertility treatments produce more boy babies

Stroke rates rising, especially in working

Congress: Prevent baby formula shortages by passing a new bill

Chinese researcher claims birth of first gene

Why some fertility treatments produce more boy babies

focus

hotspot

knowledge

focus